Work

Intedanib, a triple kinase inhibitor of VEGFR, FGFR and PDGFR for the treatment of cancer and idiopathic pulmonary fibrosis.

Year: 2010

Type: article

Source: PubMed

Authors: Sabina A Antoniu, Martin R J Kolb

Institution: Grigore T. Popa University of Medicine and Pharmacy

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W183999225

FWCI: 1.184

Cites:

Cited by: 30

Related to: 10